EQT

What they fund

• Growth Equity & Buyouts — Large-cap buyouts and growth rounds, exemplified by the €67m Series A in Amolyt Pharma and the $1.05bn acquisition of Amolyt by AstraZeneca [1]., - Venture Capital — Early to growth-stage tech investments via EQT Ventures, including early bets on Sana (2021) and IFS [1]., - Infrastructure Debt & Equity — Long-term infrastructure projects, such as the sustainability-linked loan for NFI's decarbonisation funded by 14 banks [1]., - Real Estate & Logistics — Large-scale real estate portfolios, including the acquisition of a 14-asset logistics portfolio in Europe for EUR 532 million [2].

Investment thesis

EQT operates as a global private markets firm driven by a performance philosophy that "good enough has never been enough," striving for continuous improvement and better performance [1]. The firm focuses on actively managing real assets to solve for changing needs, building value through operational improvements such as scaling EBITDA and digital transformation [1]. EQT emphasizes a long-term horizon, playing the long game to build value and trust, backed by a conviction-led approach to sourcing and executing deals [1]. The firm leverages its specialist teams and global design to unlock returns and growth for investors beyond public markets, maintaining a #2 global ranking in private equity and #5 in infrastructure by capital raised [1].

Value add

EQT provides operational support through its platform, focusing on scaling EBITDA, digital transformation, and leadership team building [1]. The firm leverages its market relationships to secure capital, as seen in NFI's sustainability-linked loan from 14 banks [1]. Fit verdict: EQT is best suited for founders seeking operational expertise and access to large-scale capital for global expansion or significant M&A activity. Founder diligence script: 1. How does EQT's operational team specifically plan to scale EBITDA in the first 12 months? 2. What is EQT's track record in supporting digital transformation within our sector? 3. How does EQT facilitate introductions to strategic buyers or co-investors for future rounds? 4. What is the expected board involvement and decision-making pace?

Portfolio focus

• Life Sciences & HealthTech — Heavy concentration in biotech and medtech, evidenced by investments in Amolyt Pharma, PolyPeptide, and Xeltis [1][2]., - Enterprise Software & AI — Significant backing in SaaS and AI-native platforms, including IFS, Sana, and Netlify [1][2]., - Infrastructure & Real Assets — Core holdings in data centers (EdgeConneX), transportation (Nordic Ferry Infrastructure), and logistics (Logicor) [1][2]., - Sustainability & Clean Tech — Investments in decarbonisation and renewable energy, such as NFI and Cypress Creek Renewables [1][3].

Notable investments & exits

• Amolyt Pharma — Acquired by AstraZeneca for up to $1.05bn after EQT led its €67m Series A and supported IPO preparation [1]., - Sana — Acquired by Workday for $1.1bn, following EQT's early investment in 2021 [1]., - EdgeConneX — Sold for $2.7bn, with EQT tripling its capacity to serve hyperscalers in cloud and AI [1][3]., - IFS — Quintupled annual revenues to €1.5bn through agentic AI implementation, demonstrating significant value creation [1].

Strategic implications

EQT's massive AUM and global footprint allow it to lead large-cap buyouts and infrastructure deals, but it may be less active in early-stage venture capital compared to specialized VC firms. The firm's focus on operational value creation and digital transformation positions it well for portfolio companies in mature markets seeking efficiency gains. EQT's strong performance in life sciences and enterprise software suggests a strategic edge in sectors requiring deep operational expertise and long-term capital.

Where they could go further

EQT could deepen its engagement in early-stage venture capital by expanding EQT Ventures' presence in emerging markets like Southeast Asia and Latin America. The firm could enhance its value proposition for founders by offering more structured mentorship programs for first-time CEOs in its portfolio companies. EQT might explore more co-investment opportunities with regional PE firms to gain deeper local market insights and deal flow.